Bellevue Group »

Waystar Holding Corp shares owned by Bellevue Group

Quarter-by-quarter ownership of Waystar Holding Corp shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Waystar Holding Corp

Tip: Access up to 7 years of quarterly data

All positions including Waystar Holding Corp held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Waystar Holding Corp by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.2M 150k 21.50

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Vertex Pharmaceuticals Incorporated (VRTX)
Neurocrine Biosciences (NBIX)
Intuitive Surgical Com New (ISRG)
Alnylam Pharmaceuticals (ALNY)
Boston Scientific Corporation (BSX)
Revolution Medicines (RVMD)
Stryker Corporation (SYK)
Moderna (MRNA)
Intra Cellular Therapies (ITCI)
Agios Pharmaceuticals (AGIO)
Abbott Laboratories (ABT)
Dex (DXCM)
Incyte Corporation (INCY)

View all positions for Bellevue Group

Top funds holding Waystar Holding Corp

Canada Pension Plan Investment Board
Bain Capital Investors
Neuberger Berman Group
Deerfield Management Company
Tpg Gp A
T. Rowe Price Investment Management
Vanguard Group
Arrowpoint Asset Management
Holocene Advisors
Morgan Stanley
American Century Companies
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Citadel Advisors
Jennison Associates

View all funds holding Waystar Holding Corp